Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001193125-26-257366

Options or other derivatives

  • Director acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Heffernan Michael Thomas · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-03 Grant or award : show line 1 in the form Nonstatutory Stock Option (right to buy) +35,000 35,000 D
Loading xslF345X06/ownership.xml…